Clarity Pharmaceuticals Ltd
Clinical trials sponsored by Clarity Pharmaceuticals Ltd, explained in plain language.
-
New 'See and Treat' approach targets tough prostate cancer
Disease control Recruiting nowThis study tests a new approach for men with advanced prostate cancer that has spread and no longer responds to hormone therapy. It uses a special molecule that finds cancer cells and delivers both a diagnostic tracer for imaging and a therapeutic dose of radiation. The goal is t…
Phase: PHASE1, PHASE2 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New PET scan could spot hidden prostate cancer spread
Diagnosis Recruiting nowThis study tests a new type of PET scan using a radioactive tracer called 64Cu-SAR-bisPSMA to see if it can better detect prostate cancer that has spread to nearby lymph nodes. About 383 men with high-risk prostate cancer who are scheduled for prostate removal surgery will get th…
Phase: PHASE3 • Sponsor: Clarity Pharmaceuticals Ltd • Aim: Diagnosis
Last updated May 19, 2026 11:47 UTC